Stem cell centers on the rise, claim high efficacy for treatment of knee osteoarthritisMedical Xpress"The claim of "stem cell" therapy carries a high level of expectations for the potential benefits, but research is still many years away… Continue reading
BioPharma-Reporter.comScientists look to gene-inserting tech for T-cell modificationBioPharma-Reporter.comOpenCell Technologies – of which Meacham is a co-founder – is interested in licensing the development of delivery and transfection applications, i… Continue reading
FierceBiotech |
Caladrius snags heart disease stem cell therapy from Shire
FierceBiotech Caladrius Biosciences picked up the worldwide rights to Shire’s late-stage CD34+ stem cell therapy for refractory angina, while the big pharma will receive an undisclosed upfront fee, milestones and a royalty on product sales. The New Jersey-based … |
FierceBiotech |
Magenta inks deal with Heidelberg to add new ADCs to its transplant palette
FierceBiotech The two companies will combine Magenta’s stem cell expertise with Heidelberg’s ATAC platform to develop ADCs loaded with a toxin (amanitin) against four undisclosed cellular targets. (rawpixel via Unsplash). Share Facebook Twitter LinkedIn Email Print … Magenta, Heidelberg Pharma Launch Bone Marrow Transplant ADC CollaborationGenetic Engineering & Biotechnology News |
|
Stab injury of zebrafish unveils regenerative processes by neural stem cells in the brain
Science Daily Ohshima’s group established a stab injury model using adult zebrafish and examined the reaction of neural stem cell called radial glia (RG) in response to injuries in the optic tectum. Little was known about the functions of RG in both the … |